Diuretic resistance in heart failure

Current Heart Failure Reports

Volumn 3, Issue 1, 2006, Pages 41-45

  Iyengar, Srinivas ^a   Abraham, William T ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUMETANIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; HYDROCHLOROTHIAZIDE; LOOP DIURETIC AGENT; METOLAZONE; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM SPARING DIURETIC AGENT; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TORASEMIDE;

CARDIOVASCULAR RISK; CLINICAL FEATURE; DIETARY INTAKE; DRUG EXCRETION; DRUG HALF LIFE; DRUG MECHANISM; DRUG SENSITIVITY; DRUG USE; HEART FAILURE; HUMAN; HYPERKALEMIA; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY HYPERTROPHY; METABOLIC ACIDOSIS; MORBIDITY; MORTALITY; OTOTOXICITY; OUTPATIENT CARE; PATIENT COMPLIANCE; REVIEW; CONGESTIVE HEART FAILURE; DRUG EFFECT; DRUG RESISTANCE; HEMODYNAMICS; KIDNEY; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

DIURETICS; DRUG RESISTANCE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; KIDNEY; RENIN-ANGIOTENSIN SYSTEM;

EID: 33749168027     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-006-0030-x     Document Type: Review

References (29)

1. American Heart Association: Heart Disease and Stroke Statistics-2005 Update. Dallas, TX; November 13-16, 2005.
2. Effects of enalapril on survival on mortality in severe congestive heart failure. Results of the Cooperative North Scandanavian Enalapril Survival Study. (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 1987, 316:1429-1435.
3. Cohn JN, Tognoni G: A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001, 345:1667-1675.
4. Packer M, Bristow MR, Cohn JN, et al.: The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 1996, 334:1349-1355.
5. Taylor AL, Ziesche S, Yancy C, et al.: Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med 2004, 351:2049-2057.
6. Hunt SA, Abraham WT, Chin MH, et al.: ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult-Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Circulation 2005, 112:1825-1852. Current guidelines of crucial management issues in patients with chronic HF.
7. Pitt B, Zannad F, Remme WJ, et al.: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999, 341:709-717.
8. Neuberg GW, Miller AB, O'Connor CM, et al.: Diuretic resistance predicts mortality in patients with advanced heart failure. Am Heart J 2002, 144:31-38. Provides important data to support the correlation of higher doses of diuretics and increased mortality in patients with chronic HF.
9. Schrier RW, Abraham WT: Hormones and hemodynamics in heart failure. N Engl J Med 1999, 341:577-585.
10. Loon NR, Wilcox CS, Unwin RJ: Mechanism of impaired natriuretic response to furosemide during prolonged therapy. Kidney Int 1989, 36:682-689.
11. Opie LH: Diuretics. In Drugs for the Heart, edn 5. Edited by Opie LH, Kaplan NM, Pool-Wilson P. Philadelphia: W.B. Saunders; 2001:84-106.
12. Brater DC: Diuretic Therapy. N Engl J Med 1998, 339:387-395.
13. Ellison DH: Diuretic resistance: physiology and therapeutics. Semin Nephrol 1999, 19:581-597.
14. Gradual NA, Galloe AM, Garred P: Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglycerides. JAMA 1998, 279:1383-1391.
15. Dzau VJ, Packer M, Lilly LS, et al.: Prostaglandins in severe congestive heart failure. Relation to activation of the renin-angiotensin system and hyponatremia. N Engl J Med 1984, 310:347-352.
16. Gerlag PG, van Meijel JJ: High-dose furosemide in the treatment of refractory congestive heart failure. Arch Intern Med 1988, 148:286-291.
17. Wollam GL, Tarazi RC, Bravo EL, et al.: Diuretic potency of combined hydrochlorothiazide and furosemide therapy in patients with azotemia. Am J Med 1982, 72:929-938.
18. Dormans TP, Gerlag PG: Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure. Eur Heart J 1996, 17:1867-1874.
19. Kiyingi A, Field MJ, Pawsey CC, et al.: Metolazone in treatment of severe refractory congestive cardiac failure. Lancet 1990, 335:29-31.
20. Channer KS, McLean KA, Lawson-Matthew P, et al.: Combination diuretic treatment in severe heart failure: a randomized controlled trial. Br Heart J 1994, 71:146-150.
21. Dormans TP, van Meyel JJ, Gerlag PG, et al.: Diuretic efficacy of high dose furosemide in severe heart failure: Bolus injection versus continuous infusion. J Am Coll Cardiol 1996, 28:376-382.
22. Lahav M, Regev A, Ra'anani P, et al.: Intermittent administration of furosemide vs. continuous infusion preceded by a loading dose for congestive heart failure. Chest 1992, 102:725-731.
23. Van Meijel JJ, Smits P, Dormans T, et al.: Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance. J Intern Med 1994, 235:329-334.
24. Salvador D, Rey N, Ramos G, et al.: Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev 2004, 1:CD003178.
25. Bayram M, De Luca L, Massie MB, et al.: Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes. Am J Cardiol 2005, 96:47G-58G. Highlights safety concerns in patients receiving these drugs during an acute decompensation of HF as well as alternate treatment options.
26. Vargo DI, Brater DC, Rudy DW, et al.: Dopamine does not enhance furosemide-induced natriuresis in patients with congestive heart failure. J Am Soc Nephrol 1996, 7:1032-1037.
27. Agostoni PG, Marenzi GC, Pepi M, et al.: Isolated ultrafiltration in moderate congestive heart failure. J Am Coll Cardiol 1993, 21:424-431.
28. Dileo M, Paciti A, Bergerone S, et al.: Ultrafiltration in the treatment of refractory congestive heart failure. Clin Cardiol 1988, 11:449-452.
29. Jaski BE, Ha J, Denys BG, et al.: Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients. J Card Fail 2003, 9:227-231.